Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
09-11 April, 2025
Not Confirmed
Not Confirmed
31 March-01 April, 2025
Plastics Recycling EUPlastics Recycling EU
Not Confirmed
Not Confirmed
01-02 April, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
09-11 April, 2025
Industry Trade Show
Not Confirmed
31 March-01 April, 2025
Plastics Recycling EUPlastics Recycling EU
Industry Trade Show
Not Confirmed
01-02 April, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/our-unmatched-efficiency-and-track-record-of-faster-dmf-filings-give-our-customers-a-critical-competitive-advantage
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/molecular-glue-degraders-lilly-abbvie-sign-billion-dollar-deals-bms-leads-with-three-late-stage-drugs
05 Feb 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/renibus-to-present-at-oppenheimers-35th-annual-healthcare-life-sciences-conference-302369302.html
24 Sep 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/renibus-therapeutics-announces-participation-at-upcoming-investor-conferences-302257550.html
07 Feb 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/renibus-therapeutics-announces-presentation-at-oppenheimer-34th-annual-healthcare-conference-302055962.html
09 Jan 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/renibus-announces-publication-of-results-from-phase-2-study-evaluating-rbt-1-as-a-pre-conditioning-agent-to-reduce-post-operative-complications-following-cardiothoracic-surgery-302029800.html
25 Oct 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/renibus-announces-first-patient-enrolled-in-protect-phase-3-study-of-rbt-1-to-reduce-post-operative-complications-after-cardiothoracic-surgery-301967256.html
10 Oct 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/renibus-therapeutics-announces-participation-at-upcoming-investor-conferences-301952536.html
ABOUT THIS PAGE